13 reports

China’s demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Blood Disease
  • China
  • Industrial Production
  • Labour Force

This study focuses on China’s Blood Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Blood Disease
  • China
  • Employment Costs
  • Hormones Sales

This study focuses on China’s Blood Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Blood Disease
  • China
  • Industrial Production
  • Labour Force

KEY FINDINGS The global apheresis market growth is estimated to progress at a CAGR of 8.31% during the forecast period, 2021-2028. The increasing elderly population, hematologic disease prevalence, favorable reimbursement policies and funding, and technological advancements in apheresis techniques drive market growth. MARKET...

  • Blood Disease
  • World
  • Elderly Population

Aplastic Anemia (Hematology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape.Aplastic anemia is a syndrome of...

  • Blood Disease
  • Drug Development
  • World
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Aplastic Anemia - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Pipeline Review, H2 2020, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape. Aplastic anemia is a syndrome of bone marrow...

  • Blood Disease
  • World
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Aplastic Anemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H1 2020, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape. Aplastic anemia is a syndrome of bone...

  • Blood Disease
  • World
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

KEY FINDINGS The global blood plasma market is projected to register a CAGR of 6.24% during the forecast period, 2020-2028. The eminent drivers of market growth are the increasing patient pool for hemophilia treatment, the rising geriatric population, the increasing occurrence of sports injuries, and the growing usage of...

  • Healthcare
  • Bioproduct
  • Research And Development
  • Blood Disease
  • Chronic Disease
  • World
  • North America

The Global Blood Purification Equipment Market size is expected to reach $19.2 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period. Blood purification refers to a method that includes blood withdrawal from the body of a patient into a machine or a device to eliminate impurities and send it back into the body....

  • Renal Disease
  • Blood Disease
  • Hospital
  • APAC
  • Europe
  • North America
  • Mortality Rate

About this market The increasing awareness about VWD is likely to boost growth in the market. VWD will be present in the affected individual since the time of birth; however, the symptoms do not appear from childhood. Patients’ perceptions of symptoms such as frequent nosebleeds, staining and extreme bleeding during and...

  • Blood Disease
  • World
  • Number Of Enterprises

The global sepsis diagnostics market is expected to reach a value of USD 874.6 million by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of sepsis is the most significant factor anticipated to drive the market growth during the forecast period. According to the National Center for Biotechnology Information,...

  • Blood Disease
  • Diagnostics
  • Hospital
  • World
  • Mortality Rate
  • Hospital Number

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment strategies for the clinical management of hematological disorders and blood cancers. - Gain insight into tests currently being...

  • Blood Disease
  • World
  • Cancer Incidence

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hundreds of diseases in clinical studies, of which about 50% is applied to blood diseases. In addition to blood diseases, tumors, neurological system...

  • Cell Therapy
  • Blood Disease
  • China
  • World